Icon

HYTRIN (nda019057)- (EQ 1MG BASE,EQ 2MG BASE,EQ 5MG BASE,EQ 10MG BASE)

TERAZOSIN HYDROCHLORIDE ABBOTT
EQ 1MG BASE,EQ 2MG BASE,EQ 5MG BASE,EQ 10MG BASE
Yes No
2013-Apr-29 Expired
None None
None No
HYTRIN (terazosin hydrochloride) is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). HYTRIN is also indicated for the treatment of hypertension. It can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 1MG BASE ** ** - - -
EQ 2MG BASE ** ** - - -
EQ 5MG BASE ** ** - - -
EQ 10MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.